We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
-0.97%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.29%
AUM
$13.5B
AUM Growth
-$537M
Cap. Flow
-$203M
Cap. Flow %
-1.51%
Top 10 Hldgs %
19.68%
Holding
385
New
13
Increased
113
Reduced
185
Closed
7

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$46.3M
2
QCOM icon
Qualcomm
QCOM
+$36.9M
3
ATKR icon
Atkore
ATKR
+$27.5M
4
WTRG icon
Essential Utilities
WTRG
+$26.1M
5
HALO icon
Halozyme
HALO
+$19.4M

Top Sells

Rank Stock Value
1
MEDP icon
Medpace
MEDP
+$43.2M
2
CPE
Callon Petroleum Company
CPE
+$35.4M
3
UMBF icon
UMB Financial
UMBF
+$31M
4
SLB icon
SLB Ltd
SLB
+$30.8M
5
JPM icon
JPMorgan Chase
JPM
+$27.7M

Sector Composition

Rank Sector Weight
1 Technology 24.52%
2 Financials 14.32%
3 Healthcare 14.05%
4 Industrials 13.81%
5 Consumer Discretionary 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VO icon
251
Vanguard Morningstar Mid-Cap ETF
VO
$105B
$1.87M 0.01%
30,820
BRK.A icon
252
Berkshire Hathaway Class A
BRK.A
$1.1T
$1.84M 0.01%
3
RY icon
253
Royal Bank of Canada
RY
$283B
$1.62M 0.01%
15,190
-65,500
-81% -$6.74M
BAC icon
254
Bank of America
BAC
$416B
$1.59M 0.01%
39,908
-1,733
-4% -$66.4K
SPGI icon
255
S&P Global
SPGI
$122B
$1.58M 0.01%
3,548
-50
-1% -$21.5K
IWR icon
256
iShares Russell Mid-Cap ETF
IWR
$55.4B
$1.57M 0.01%
19,325
WM icon
257
Waste Management
WM
$86.8B
$1.55M 0.01%
7,279
+28
+0.4% +$5.82K
REGN icon
258
Regeneron Pharmaceuticals
REGN
$79.7B
$1.55M 0.01%
1,473
AMCR icon
259
Amcor
AMCR
$19.6B
$1.52M 0.01%
30,984
PH icon
260
Parker-Hannifin
PH
$117B
$1.49M 0.01%
2,950
BF.A icon
261
Brown-Forman Class A
BF.A
$12.2B
$1.43M 0.01%
32,400
IVV icon
262
iShares Core S&P 500 ETF
IVV
$837B
$1.41M 0.01%
2,576
-55
-2% -$28.9K
SNPS icon
263
Synopsys
SNPS
$70.5B
$1.39M 0.01%
2,333
-114
-5% -$64.5K
KMB icon
264
Kimberly-Clark
KMB
$32.8B
$1.35M 0.01%
9,758
-500
-5% -$66.8K
AWK icon
265
American Water Works
AWK
$27.4B
$1.34M 0.01%
10,360
+8,060
+350% +$1.02M
CVS icon
266
CVS Health
CVS
$121B
$1.27M 0.01%
21,585
-119,121
-85% -$7.45M
VUG icon
267
Vanguard Morningstar Growth ETF
VUG
$224B
$1.25M 0.01%
20,004
TGT icon
268
Target
TGT
$70.1B
$1.23M 0.01%
8,328
-115
-1% -$18.1K
SAP icon
269
SAP
SAP
$249B
$1.21M 0.01%
5,995
-36,750
-86% -$6.94M
NSC icon
270
Norfolk Southern
NSC
$71.9B
$1.21M 0.01%
5,617
CMI icon
271
Cummins
CMI
$74.1B
$1.2M 0.01%
4,345
-765
-15% -$219K
ED icon
272
Consolidated Edison
ED
$38.9B
$1.2M 0.01%
13,438
XLK icon
273
State Street Technology Select Sector SPDR ETF
XLK
$119B
$1.17M 0.01%
10,332
TMO icon
274
Thermo Fisher Scientific
TMO
$237B
$1.14M 0.01%
2,059
-44
-2% -$25.2K
PSX icon
275
Phillips 66
PSX
$106B
$1.06M 0.01%
7,493
-1,850
-20% -$274K

Similar funds

Boston Trust Walden's Q2 2024 Portfolio in Review

As of Q2 2024, Boston Trust Walden held 385 positions worth $13.5B, down 3.8% from $14B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Boston Trust Walden's Q2 2024 filing shows 13 new, 113 increased, 185 reduced and 7 closed positions. Its largest new stake was Atkore: 172,729 shares worth $23.3M. The largest sale was Medpace, an estimated $43.2M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • Boston Trust Walden's largest Q2 2024 buy was Atkore: 172,729 shares worth $23.3M.
  • Boston Trust Walden added most to NVIDIA in Q2 2024, an estimated $46.3M increase.
  • Boston Trust Walden's biggest Q2 2024 reduction was Medpace, cutting an estimated $43.2M.
  • Boston Trust Walden fully exited Callon Petroleum Company in Q2 2024, selling an estimated $35.4M.
  • Boston Trust Walden's ten largest holdings make up 20% of its $13.5B portfolio in Q2 2024.
  • Boston Trust Walden opened 13 new positions and closed 7 in Q2 2024.
  • Boston Trust Walden's portfolio value fell 3.8% quarter-over-quarter to $13.5B.

Based on Boston Trust Walden's 13F filing for Q2 2024, filed 19 Jul 2024.